Hematopoeitic Progenitor Cell (HPC) Donor and Patient Safety Issues
Program Code: 212-TC
Sunday, October 24, 2004
8:30 AM to 12:00 PM (ET)

SPEAKERS
Chatchada Karanes, MD, National Marrow Donor Program
Edward Snyder, MD, Yale University School of Medicine/Yale-New Haven Hospital
Scott D. Rowley, MD, Hackensack University Medical Center
Jay H. Herman, MD, Thomas Jefferson University

DESCRIPTION
This program presents safety issues involving donation and infusion of HPCs including risk assessment of marrow harvest, peripheral blood apheresis collection, HPC mobilization of normal donors, adverse reactions to HPC infusion and HPC product quality control. Vignettes of donor evaluation decisions provide clinical relevance and illustration.

OBJECTIVES

• Describe the differences between HPC and whole blood donor assessment
• Recognize the safety concerns of marrow donation
• Manage the common complications of HPC apheresis collection
• Define the health risks of HPC mobilization of donors
• Evaluate adverse reactions to HPC infusion

AUDIENCE
Physicians, Technologists, Nurses, Managers/Supervisors

PROGRAM LEVEL
Intermediate